Literature DB >> 7189827

Biphasic effects of direct, but not indirect, GABA mimetics and antagonists on haloperidol-induced catalepsy.

P Worms, K G Lloyd.   

Abstract

At very low doses the GABA agonists SL 76002 and muscimol diminish haloperidol-induced catalepsy. At somewhat higher doses these compounds potentiate catalepsy. Biphasic effects on DA-receptor mediated functions have previously been noted with bicuculline and picrotoxinin. In contrast, manipulation of GABA levels by enzyme inhibition induced only a monophasic effect on dopamine-mediated behaviour. The potentiation of GABA levels by enzyme inhibition induced only a monophasic effect on dopamine-mediated behaviour. The potentiation of haloperidol-induced catalepsy by GABA mimetics is also observed with dipropylacetate, delta-aminovaleric acid and gamma-acetylenic GABA. This GABA-mimetic potentiation of catakepsy was blocked by the coadministration of bicuculline. These results confirm and extend the hypothesis that GABA-neurons influence DA neuron function. Furthermore they suggest that more than one group of GABA receptors influence directly and/or indirectly DA neuronal function, with different resultant effects.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7189827     DOI: 10.1007/bf00510257

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  37 in total

1.  The effect of 4-amino hex-5-ynoic acid (gamma-acetylenic GABA, gammma-ethynyl GABA) a catalytic inhibitor of GABA transaminase, on brain GABA metabolism in vivo.

Authors:  M J Jung; B Lippert; B W Metcalf; P J Schechter; P Böhlen; A Sjoerdsma
Journal:  J Neurochem       Date:  1977-04       Impact factor: 5.372

2.  GABA receptor binding with 3H (+) bicuculline-methiodide in rat CNS.

Authors:  H Mohler; T Okada
Journal:  Nature       Date:  1977-05-05       Impact factor: 49.962

3.  Regulation of nigro-striatal dopaminergic neurotransmission in the rat.

Authors:  A Dray; L J Fowler; N R Oakley; M A Simmonds; T Tanner
Journal:  Neuropharmacology       Date:  1977 Jul-Aug       Impact factor: 5.250

4.  Muscimol binding in rat brain: association with synaptic GABA receptors.

Authors:  K Beaumont; W S Chilton; H I Yamamura; S J Enna
Journal:  Brain Res       Date:  1978-06-09       Impact factor: 3.252

5.  Influence of GABA-agonists and antagonists on neuroleptic-induced catalepsy in rats.

Authors:  P Worms; K G Lloyd
Journal:  Life Sci       Date:  1978-08-07       Impact factor: 5.037

6.  Evidence for an intrastriatal GABA-ergic influence on dopamine neurones of the cat.

Authors:  G Bartholini; H Stadler
Journal:  Neuropharmacology       Date:  1977-05       Impact factor: 5.250

7.  Audiogenic seizure protection by elevated brain GABA concentration in mice: effects of gamma-acetylenic gaba and gamma-vinyl GABA, two irreversible GABA-T inhibitors.

Authors:  P J Schechter; Y Tranier; M J Jung; P Böhlen
Journal:  Eur J Pharmacol       Date:  1977-10-15       Impact factor: 4.432

8.  Interaction of benzodiazepines with neuroleptics at central dopamine neurons.

Authors:  H H Keller; R Schaffner; W Haefely
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1976-07       Impact factor: 3.000

Review 9.  Sodium valproate: a review of its pharmacological properties and therapeutic efficacy in epilepsy.

Authors:  R M Pinder; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-02       Impact factor: 9.546

10.  New anticonvulsants: Schiff bases of gamma-aminobutyric acid and gamma-aminobutyramide.

Authors:  J P Kaplan; B M Raizon; M Desarmenien; P Feltz; P M Headley; P Worms; K G Lloyd; G Bartholini
Journal:  J Med Chem       Date:  1980-06       Impact factor: 7.446

View more
  6 in total

1.  Proceedings of the British Pharmacological Society. University of Southampton, 17th-19th July 1985. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

2.  Dopamine-like activities of an aminopyridazine derivative, CM 30366: a behavioural study.

Authors:  P Worms; J P Kan; C G Wermuth; K Biziere
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-11       Impact factor: 3.000

3.  SR 46559A: a novel and potent muscarinic compound with no cholinergic syndrome.

Authors:  J P Kan; R Steinberg; F Oury-Donat; J C Michaud; O Thurneyssen; J P Terranova; C Gueudet; J Souilhac; R Brodin; R Boigegrain
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

4.  Evidence for down-regulation of GABA receptors following long-term gamma-butyrolactone.

Authors:  G Gianutsos; P D Suzdak
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-11       Impact factor: 3.000

5.  Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.

Authors:  Anna Wisniecki; Merce Correa; Maria N Arizzi; Keitha Ishiwari; John D Salamone
Journal:  Psychopharmacology (Berl)       Date:  2003-06-24       Impact factor: 4.530

6.  Synergistic anticonvulsant effects of GABA-T inhibitors and glycine.

Authors:  N Seiler; S Sarhan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.